Post by Johnson & Johnson Innovative Medicine Ireland

How can Ireland build on a 50% improvement in cancer survival rates in just a decade? At the All-Island Cancer Summit, Margaret Doyle, a global medical affairs leader in haematology here at J&J, discussed the roadmap: relentless innovation, robust clinical trial reform, and unwavering patient-centricity. Read her article in full below.